Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer
about
The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cellsSSRP1 functions as a co-activator of the transcriptional activator p63Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancersThe recruitment of SOX/OCT complexes and the differential activity of HOXA1 and HOXB1 modulate the Hoxb1 auto-regulatory enhancer functionEffects of B-Myb on gene transcription: phosphorylation-dependent activity ans acetylation by p300Identification of an upstream enhancer within a functional promoter of the human leukemia inhibitory factor receptor gene and its alternative promoter usageFGF4, a direct target of LEF1 and Wnt signaling, can rescue the arrest of tooth organogenesis in Lef1(-/-) miceFbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse developmentSOX7 and GATA-4 are competitive activators of Fgf-3 transcriptionNew POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2SOX2 is a dose-dependent regulator of retinal neural progenitor competenceReciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cellsCharacterization of the rat type III hexokinase gene promoter. A functional octamer 1 motif is critical for basal promoter activity.OCT3/4 regulates transcription of histone deacetylase 4 (Hdac4) in mouse embryonic stem cells.Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer.Fiber-type-specific transcription of the troponin I slow gene is regulated by multiple elementsCoevolution of HMG domains and homeodomains and the generation of transcriptional regulation by Sox/POU complexes.Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site.Sox2 transcriptionally regulates PQBP1, an intellectual disability-microcephaly causative gene, in neural stem progenitor cellsTranscription factor heterogeneity and epiblast pluripotency.Oct4 distribution and level in mouse clones: consequences for pluripotencyElevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genesRepression of gonadotropin-releasing hormone promoter activity by the POU homeodomain transcription factor SCIP/Oct-6/Tst-1: a regulatory mechanism of phenotype expression?SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen geneRegulation of the Nanog gene by both positive and negative cis-regulatory elements in embryonal carcinoma cells and embryonic stem cellsDifferent transcription factors regulate nestin gene expression during P19 cell neural differentiation and central nervous system development.Differential regulation of the Oct-3/4 gene in cell culture model systems that parallel different stages of mammalian development.Fibroblast growth factor-8 expression is regulated by intronic engrailed and Pbx1-binding sites.Comparative FAIRE-seq analysis reveals distinguishing features of the chromatin structure of ground state- and primed-pluripotent cells.The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2.Banf1 is required to maintain the self-renewal of both mouse and human embryonic stem cells.The POU homeodomain transcription factor Oct-1 is essential for activity of the gonadotropin-releasing hormone neuron-specific enhancer.Conformational alteration of Oct-1 upon DNA binding dictates selectivity in differential interactions with related transcriptional coactivators.Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sitesDifferential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells.Effects of three Sp1 motifs on the transcription of the FGF-4 gene.Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation.Testis expression of hormone-sensitive lipase is conferred by a specific promoter that contains four regions binding testicular nuclear proteins.Regulatory mechanisms governing FGF-4 gene expression during mouse development.
P2860
Q24530311-1A63A31C-0FEF-4352-A94C-86E7B74AAB87Q24534925-DA33C339-8BBB-4CF3-92D5-DC0F4460F168Q24671880-E5C28EC1-4103-49CA-AAA5-1E80D93856F5Q28208370-D12A3EE0-939D-4D64-A7D0-C445F4E2BDB1Q28208710-DAB6C067-4633-4FAF-85DD-195EF2AC1F30Q28252856-D32BAF0A-D22A-4039-80D6-92A1D4111547Q28505123-3F01B3E5-F6A9-4829-B187-273DB7745183Q28506535-591A1965-C977-4CF6-9DD6-1A342DB62CFFQ28508654-D0DA60FC-5E66-428B-B402-EBE42BBC0826Q28585451-4632E624-6174-43F8-9599-6E1CCAFE58FCQ28592758-4A8B3AD0-8A1F-4513-905E-FC4942A52700Q28594516-E72D2335-A4D2-4DEF-89C5-D498A3501A70Q30798735-9FBFE620-91A8-468D-9A37-4059C9285F8AQ33588838-D4B98CAB-3483-4366-A229-E44EE0219A71Q33901106-EF69920A-C247-4D11-A07B-6248A2B4CBB3Q33957173-230E8FBB-84E3-47B3-A785-1AE3DC201C04Q34136343-15446C2D-8AC4-4300-8980-220B69311CBFQ34462681-1F4F1082-DE07-4793-B267-DB0B5692E989Q34849912-598E1ED1-4D37-4007-93CC-20E00BB13689Q35088540-63BBD6DD-B44C-4C0E-ACFC-12635A98D4E6Q35776783-BBDA6234-0A49-439A-8D4A-391874AE2EDDQ35804584-828BB6CC-6084-40B8-980C-13DD324E5E4CQ36566150-D109AF01-34FB-4D9E-A82F-D735B48D8A91Q36567842-434DD56D-1F3E-42CC-9F63-F6F9D0C7B542Q37038485-3382F9D2-7BD9-454F-8D68-3E18A4BABC4DQ37134462-894E5547-9761-4846-B166-3D9A6B9EF005Q38294309-248E3861-2161-4E2C-BC16-10F3BC644D2DQ38327908-18B8EB1A-F288-4598-B97D-532C33B7F803Q38946044-56D00A15-F513-435A-9786-C109E85A4696Q39446613-A8D0EC62-B6AC-4BB6-8D65-DE8D7AE0464CQ39507999-E029B150-47B8-4309-8D27-A4474B08FA2AQ40017557-84095881-12F2-42B1-A9EB-C9C57834BF8FQ40019582-E226A1BC-C0FC-49EF-A45B-57810B1140ABQ40023727-3DFD3B70-F946-41DF-9ED8-4D0941B39133Q40307639-38E22440-AC56-4972-A081-21813DEB09CFQ40489188-CC90E18D-D829-4757-92D7-92DB12147FF3Q40859373-1026E7C0-095F-4AA5-A486-C1676133CA93Q40939790-AA41215F-E630-41E8-A1D2-ED7B169DD998Q40964947-9AA5F4D7-D470-4E71-BA2D-BE68C94A23A1Q41640461-710904DF-3468-4046-A58A-669F3FC2EC09
P2860
Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer
description
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1994
@ast
im Dezember 1994 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1994/12/01)
@sk
vědecký článek publikovaný v roce 1994
@cs
wetenschappelijk artikel (gepubliceerd op 1994/12/01)
@nl
наукова стаття, опублікована в грудні 1994
@uk
مقالة علمية (نشرت في ديسمبر 1994)
@ar
name
Interaction between a novel F9 ...... blast growth factor 4 enhancer
@ast
Interaction between a novel F9 ...... blast growth factor 4 enhancer
@en
Interaction between a novel F9 ...... blast growth factor 4 enhancer
@nl
type
label
Interaction between a novel F9 ...... blast growth factor 4 enhancer
@ast
Interaction between a novel F9 ...... blast growth factor 4 enhancer
@en
Interaction between a novel F9 ...... blast growth factor 4 enhancer
@nl
prefLabel
Interaction between a novel F9 ...... blast growth factor 4 enhancer
@ast
Interaction between a novel F9 ...... blast growth factor 4 enhancer
@en
Interaction between a novel F9 ...... blast growth factor 4 enhancer
@nl
P2093
P2860
P356
P1476
Interaction between a novel F9 ...... blast growth factor 4 enhancer
@en
P2093
P2860
P304
P356
10.1128/MCB.14.12.7758
P407
P577
1994-12-01T00:00:00Z